December 6-7, 2017 Princeton, NJ

Companion Diagnostics Forum

DEMONSTRATING THE VALUE OF COMPANION DIAGNOSTICS
FOR PRECISION BIOLOGICS AND SMALL MOLECULE DRUGS

Register Now

COMPANION DIAGNOSTICS FORUM 2017

Demonstrating the Value of Companion Diagnostics
for Precision Biologics and Small Molecule Drugs

Companion Diagnostics (CDx) and Complementary Diagnostics have now been available for several years. Notable examples of Companion Diagnostics include Xalkori and Ventana ALK (D5F3) CDx Assay; Gleevec and Dako C-KIT PharmDx; Keytruda and Dako PD-L1 IHC 22C3 pharmDx; Tarceva and cobas® EGFR Mutation Test v2; and Herceptin and Pathvysion HER-2 DNA Probe Kit. Not only must CDx-drug pairs demonstrate therapeutic utility, Pharma/Biotech and their business partners must realize net financial benefits. In this conference, strategies and examples in Companion Diagnostics development and use will be presented and discussed.

What is a Companion Diagnostic? The FDA’s definition:

A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.
Companion diagnostics can:

identify patients who are most likely to benefit from a particular therapeutic product;
identify patients likely to be at increased risk for serious side effects as a result of treatment with a particular therapeutic product; or
monitor response to treatment with a particular therapeutic product for the purpose of adjusting treatment to achieve improved safety or effectiveness.

Talk Recordings from the Companion Diagnostics 2016 are available to view, you will just need to fill in a simple form to view.

Featured Keynote Speakers

Nic Dracopoli

Vice President and Head of Oncology Diagnostics

Janssen

Steve Anderson

Chief Scientific Officer and Senior Vice President

Covance

Michele Cleary

Chief Executive Officer

Mark Foundation

Discounted Attendee Registration

$200 Early-Bird Attendee Registration is now available for a limited time.

Register Now

Companion Diagnostics Forum

COMPANION DIAGNOSTICS FORUM 2017

Demonstrating the Value of Companion Diagnostics for Precision Biologics and Small Molecule Drugs

Featured Keynote Speakers

Nic Dracopoli

Nic Dracopoli

Vice President and Head of Oncology Diagnostics

Steve Anderson

Steve Anderson

Chief Scientific Officer and Senior Vice President

Michele Cleary

Michele Cleary

Chief Executive Officer

Discounted Attendee Registration

$200 Early-Bird Attendee Registration is now available for a limited time.

Demonstrating the Value of Companion Diagnostics
for Precision Biologics and Small Molecule Drugs